[Managing side effects of androgene deprivation in prostate cancer]

MeSH terms

• Antineoplastic Agents, Hormonal / adverse effects*
• Antineoplastic Agents, Hormonal / therapeutic use*
• Combined Modality Therapy
• Humans
• Male
• Neoplasms, Hormone-Dependent / blood
• Neoplasms, Hormone-Dependent / drug therapy*
• Orchiectomy
• Prostatic Neoplasms / blood
• Prostatic Neoplasms / drug therapy*
• Testosterone / blood